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Background: Darjeeling tea, a most popular variety of black tea, though consumed by the people in different parts
of world but its beneficial health effects have not been investigated in details. In this study, the antimutagenic and
anticancer effect of Darjeeling tea extract (DTE) has been evaluated.
Methods: Antimutagenic activity of the DTE was carried out in two different strains of Salmonella typhimurium by
AMES test against a known mutagen benzo[a]pyrene (B[a]P) with S9 activation. Moreover, anticlastogenic property
of DTE was also measured by micronuclei formation (MN) against B[a]P with S9 activation in human lymphocytes.
The anticancer activity of the same was studied on U937 cell line. Here, Human PBMCs were used as the normal
cell control to identify selective anticancer activity of the extract against U937 cells.
Results: The results showed significant antimutagenic activity on bacterial strains. A significant decrease in MN was
also observed in the DTE treated human lymphocyte cultures pretreated with B[a]P when compared with B[a]P
treated cultures alone. The study clearly exhibited anticancer activity of the extract on U937 cell line. Further studies
also revealed that apoptosis induction is an important mechanism behind the anticancer effect of DTE.
Conclusion: Overall, this study indicates that DTE has significant antimutagenic and anticancer activities on
bacterial and mammalian cells respectively.
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Tea, made from the tender shoots (two leaves and a
bud) of the plant Camellia sinensis L. is the second most
popular beverage of the world after water. According to
its processing, tea can be classified into few categories of
which two types are most common viz. green tea and
black tea. Since last few decades tea has received a great
deal of attention due to their beneficial health effects [1].
It has been found that tea is rich in substances, such as
polyphenols, which are capable of reducing the risk of a
variety of human illnesses, including cancer or uncon-
trolled cell proliferation [2]. It is known that transition
of a normal cell to a cancer cell is a multi-step process
which is triggered by genetic mutations.
Epidemiological and laboratory studies have indicated
that regular consumption of tea has been associated with
reduced risk of several forms of cancer in human and* Correspondence: akgiri15@yahoo.com
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article, unless otherwise stated.also in mouse experimental model [3,4]. Scientific stud-
ies have also revealed that tea is able to reduce the DNA
mutation rate. It is known that tea extracts have antimu-
tagenic [5-8] and anticancer activities [9-17]. Though
Black tea is more common than green tea, until recently,
tea research related to human health, has mostly been
focused on green tea. However, recent studies indicate
that black tea can also provide health benefits similar to
that of green tea [18].
Darjeeling teas are the highest grown teas in the world
in terms of altitude and preferred for its flavour, aroma
and quality throughout the world from centuries [19]. It
is also considered to be one of the most delicate kinds of
tea worldwide. But, there is hardly any report on its anti-
mutagenic and anticancer activities to date. Therefore,
this study was aimed to investigate the antimutagenic
and anticancer potential of Darjeeling tea extract (DTE)
by different standard laboratory methods.entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Materials
Darjeeling tea (cultivated at 2800 m of elevation) sample
was kindly provided by Tea Board, Kolkata, India. Agar
and nutrient broth were purchased from HiMedia la-
boratories Ltd (India). RPMI 1640 medium liquid from
Hyclone (Utah, USA), penicillin, and streptomycin were
obtained from Pan Biotech (Aidenbach, Germany), gen-
tamycin from Cambrex Bio Science Walkersville Inc (MD,
USA), cell proliferation reagent WST-1 [2-(4-Iodophenyl)-
3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium]
was obtained from Roche Diagnostics (Indianapolis, Indi-
ana, USA), Alexa Fluor 488 annexin V/Dead Cell Apop-
tosis Kit with Alexa Fluor 488 annexin V and PI for Flow
Cytometry, fetal bovine serum (FBS), phytohemagglutinin
(M form) and amphotericin (B from) were purchased
from Invitrogen (Carlsbad, CA, USA), caspase protease
assay kit was purchased from Chemicon International
Corporation (Temecula, CA, USA), Mitochondria/Cytosol
fractionation kit from BioVision (Mountain View, CA,
USA), Primary antibody of cytochrome c and β-actin and
polyclonal secondary antibody were obtained from Cell
Signaling Technology (Danvers, MA, USA). The Bio-Rad
Protein Assay Kit was from Bio-Rad Laboratories (Hercules,
CA, USA). Biotin, histidine, nicotinamide adenine dinucleo-
tide phosphate (NADP), glucose-6- phosphate, ampicillin
trihydrate, tetracycline, cytochalasin B, benzo[a]pyrene (B[a]P),
dimethyl sulphoxide (DMSO), Dithiothreitol (DTT), colchi-
cines, Tween-20, NBT/BCIP, absolute ethanol, isopropanol,
agarose, and tris-acetate buffer were purchased from from
Sigma-Aldrich Co. (St. Louis, MO, USA).Bacterial strains
For antimutagenicity assays, Salmonella strains TA98
and TA100 were used. These strains were kindly pro-
vided by Dr. Bruce N. Ames, Biochemistry Division,
University of California, Berkeley, USA.Animal
Charles River male rats of 150–175 g. were used for the
preparation of liver homogenate (S9) for bacterial anti-
mutagenicity assays. Four animals were kept per cage
with husk bedding which were received from the animal
house of our institute and were fed balanced rodent pel-
let diet (Gold Mohar, Lipton Ltd., Chandigarh, India)
and water. The animals were kept in an environment
with controlled 12 h light and 12 h dark cycle. Ambient
temperature and relative humidity were kept 22° ± 2°C
and 55% ± 5% respectively. All experimental procedures
on animals were approved by the Institutional Animal
Ethics Committee of CSIR-Indian Institute of Chemical
Biology.Preparation of S9 fraction
The procedure of Ames et al. [20] and Garner et al. [21]
was used for the preparation of rat liver homogenate
(S9). Charles river male rats of 150–175 g were fed 0.1%
phenobarbital in their drinking water for seven days. On
day 6, no foods were provided for these rats. The next
day, they were killed for the rat liver homogenate. S9
mix was prepared following the method of Maron and
Ames [22]. All steps were performed at 0° to 4°C with
cold and sterile solutions and glassware. S9 fractions
were distributed in 2 ml aliquots in small sterile plastic
tubes, quickly frozen and stored at −80°C.
Preparation of Darjeeling tea extract (DTE)
Darjeeling tea (100 g) was brewed in boiling water
(1000 ml) for 2 minutes and filtered. Then the extract
was evaporated to dryness by rotatory evaporator to
yield around 8 g of whole tea extract denoted as DTE.
Mutagenicity and antimutagenicity assays in
preincubation tests
Standard mutagenicity assays in preincubation tests were
performed for both mutagenicity and antimutagenicity
assays [22]. DTE was dissolved in DMSO and different
concentrations of DTE (1, 10, 100, 500, 1000 μg/plate)
were used in both mutagenicity assay and antimutageni-
city assay against known mutagen B[a]P. A similar ex-
periment was carried out with B[a]P (50 μg/plate) alone,
with metabolic activation (S9 mix), which served as posi-
tive control. For preincubation tests bacteria, different con-
centrations of DTE, positive compound B[a]P (50 μg/plate)
and phosphate buffer were co-incubated in the S9 mix for
20 min at 37°C and then top agar was added to it. Within
1 h the plates were inverted and placed in a dark, vented
incubator at 37°C for 48 h. Four plates were used for each
concentrations tested and for both positive and negative
controls.
Finally, the revertant colonies on the test plates were
counted. The experiment was repeated twice with simi-
lar set up. All these experiments were carried out using
liver homogenate (S9) fractions for both the strains.
Presence of background lawn on all the plates was con-
firmed. The spontaneous reversion rates of these two
different Salmonella strains were checked and those
were similar as reported by other authors.
Micronucleus assay (MN) in vitro in human lymphocytes
Blood samples were collected from six healthy individ-
uals (3 male and 3 female) and for MN analysis lympho-
cytes were cultured following the protocol of Fenech
[23]. For this work, Human Ethical committee permis-
sion was taken from the Human Ethical Committee of
CSIR-Indian Institute of Chemical Biology to collect hu-
man blood samples and all work was done according the
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man subjects for the use of their blood in research. After
collection, whole blood (0.7 ml) was added to 7 ml of
RPMI 1640 supplemented with L-glutamine, 15% FCS,
penicillin (100 IU/ml), streptomycin (100 μg/ml) and 2%
phytohemaglutinin M-form. From each blood samples
ten cultures were carried out. After the 24 h of initial in-
cubation B[a]P (100 μM) plus S9 mix were added to four
cultures from each samples and then incubated for 3 h
[24]. The cultures were then washed twice with RPMI
medium containing 1% FCS. Then four concentrations
(25, 50, 100, 200 μg/ml) of DTE were dissolved in DMSO
and were added to the above mentioned cultures. After
initial 24 h of incubation, one culture from each sample
was treated with only B[a]P and S9 mix which served as
positive control. One culture from each sample was also
treated with DMSO plus S9 mix only which will serve as
negative control at the same time point. Other remaining
cultures were treated with different concentrations (25,
50, 100, 200 μg/ml) of DTE only which also serve as DTE
treated control at the same time in parallel. Then all the
ten cultures from each sample were further incubated for
another 20 h and then cytochalasin B was added to each
culture at the final concentration 6 μg/ml and the cultures
were incubated for an additional 28 h. After a total of 72 h
of incubation, the cells were centrifuged at approximately
1000 rpm for 5 min. Supernatant was discarded and cell
pellets were treated with a hypotonic solution. Cells were
mixed with freshly prepared methanol: acetic acid (3:1) for
10 min and then centrifuged at approximately 1000 rpm
for 5 min. After air drying the slides were stained with 4%
Giemsa in phosphate buffer, pH 7.3, for 10 min. At least
2000 cytokinesis-blocked binucleated human lymphocytes
with preserved cytoplasm were scored whenever possible
from each of the six donors for all the concentrations
tested. MNs were identified in accordance with the criteria
followed by Fenech et al. [25].
Cell culture
U937 (Human Histiocytic Lymphoma) cell was obtained
from National Centre for Cell Science (NCCS), Pune,
India. The cells were cultured in RPMI 1640 medium,
supplemented with 10% heat inactivated and sterile fetal
bovine serum (FBS), penicillin (100 units/ml), strepto-
mycin (100 μg/ml), gentamycin (100 μg/ml) and ampho-
tericin B (1.2 mg/ml) and incubated at 37°C in a
humidified atmosphere containing 5% CO2 inside a CO2
incubator.
Isolation of PBMCs (Peripheral blood mononuclear cells)
PBMCs were isolated from heparinized whole blood of
normal human by density gradient centrifugation on
Histopaque. Briefly, fresh heparinized blood was mixed
with equal volume of PBS. 10 ml of diluted blood wasgently layered on 5 ml of Histopaque in a 15 ml conical
tube and centrifuged at 2000 rpm at 4°C for 40 minutes
with no brake. Cells were collected from the white inter-
phase between the plasma and transparent fraction and
resuspended in RPMI-1640 with 10% heat-inactivated
fetal bovine serum and maintained at 37°C in a humidi-
fied atmosphere containing 5% CO2 inside an incubator
for 2 hours on cell culture dishes. After that non-
adherent cells were washed out gently and the rest of
the PBMCs were used in cell viability assay as normal
cells.
Cell viability assay using WST-1
PBMCs and U937 cells were obtained from culture
medium and loaded in a haemocytometer for cell count
before plating of the cells. 105 cells were plated per well
in 96 well plates and treated with DTE. Four concentra-
tions (25, 50, 100, 200 μg/ml) of DTE including a con-
trol (0.05% DMSO) were administered in triplicate.
Campothecin B (5 μM, final concentration) was used as
a positive control to check the assay was functioning
correctly. The plates were incubated for 24 h, 48 h and
72 h respectively at 37°C in a humidified atmosphere
containing 5% CO2. Cell viability was measured using
WST-1 following manufacturer’s protocol. Briefly, 10 μl
of WST-1 reagent was added to each well and incubated
for 3 h. Absorbance was measured at 450 nm using an
ELISA reader (Beckman Coulter, CA, USA) with a refer-
ence serving as blank. The viability of control cells were
taken as 100% and were measured from the absorbance
value. The viability of treated cells were calculated simi-
larly from the absorbance values and expressed as per-
centage of control viability.
Detection of apoptosis by flow cytometry
U937 cells (1X106 in each case) were treated with differ-
ent concentrations (25, 50, 100 μg/ml) of DTE for
48 hours along with positive and negative controls as
mentioned in the previous section. Apoptosis was mea-
sured using AnnexinV-PI Apoptosis Detection Kit. U937
cells were harvested and PI and Annexin V conjugated
fluos were added to the medium and then analyzed on
flow-cytometer (Becton Dickinson, San Diego, CA; with
488 nm argon laser light source; 530 nm band pass filter
for Alexa fluor 488-fluorescence and 623 nm band pass
filter for PI- fluorescence) using CellQuest software. A
total of 10,000 events were acquired and the cells were
properly gated for analysis.
Detection of apoptosis by confocal microscopy
U937 cells (106 cells/ml) were cultured in a 60-mm cul-
ture dishes initially for 24 h and then treated with 0, 25,
50, and 100 μg/ml doses of DTE for 48 h along with the
respective controls. The cells were treated with DAPI for
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AnnexinV to detect phosphatidylserine at the outer
surface of cell membrane. Stained nuclei and phophati-
dylserine were visualized and photographed using a
Nikon A1R laser scanning confocal microscope (Nikon
Inc, Melville, New York, USA). DAPI (excitation at 350 nm
and emission at 470 nm) and Fluorescein Isothiocyanate
(FITC) (excitation at 490 nm and emission at 525 nm) were
excited by the argon–krypton laser. Apoptosis was charac-
terized by detecting externalization of phosphatidylserine.Measuring activity of caspase-3
Activity of Caspase-3 was assayed using caspase-3 fluore-
metric assay kit. U937 cells (2×106) were treated with three
different concentrations of DTE (0, 25, 50, 100 μg/ml) for
48 h and the activity was determined fluorimetrically (exci-
tation, 400 nm and emission 505 nm).Table 1 Antimutagenic effect of fractions Darjeeling tea
extract (DTE) in Salmonella strains TA98 and TA100 in
preincubation tests
DTE (μg/plate) Mean ± SD plus S9 mix
TA 98
Control (100 μl of DMSO) 52 ± 12
B[a]P (50 ug/plate) 256 ± 23
B[a]P + 1 247 ± 21
B[a]P + 10 240 ± 18
B[a]P + 100 212 ± 20 **
B[a]P + 500 167 ± 16 **
B[a]P + 1000 106 ± 17 **
TA 100
Control (100 μl of DMSO) 138 ± 12
B[a]P (50 μg/plate) 786 ± 34
B[a]P + 1 770 ± 25
B[a]P + 10 737 ± 21
B[a]P + 100 695 ± 36 *
B[a]P + 500 512 ± 24 **
B[a]P + 1000 440 ± 37 **
Each data represented as Mean ± SD of four plates. Results of each
concentration of DTE plus positive mutagen benzo[a]pyrene (B[a]P) were
compared with the positive mutagen treated group alone (all in presence of
S9 mix) by Dunnett’s multiple comparison. *P < 0.05, **P < 0.01.Preparation of cytosolic fraction and western blot analysis
of cytochrome c
U937 cells were harvested after treatment with 0, 25, 50
and 100 μg/ml concentrations of DTE for 48 h. Isolation
of a highly enriched mitochondrial fraction and cytosolic
fraction of cells was performed using a Mitochondria/
Cytosol fractionation kit. Briefly, U937 cells (5 × 107)
were centrifuged at 600 g for 5 min at 4°C, resuspended
in ice-cold PBS and centrifuged at 600 g for 5 min at 4°C.
Then the cells were resuspended in 1.0 ml of cytosol ex-
traction buffer mix containing DTT and protease inhibi-
tors and incubated on ice for 10 min. The cells were
homogenized on ice. The homogenate was centrifuged at
700 g for 10 min at 4°C and the supernatant was collected
and centrifuged at 10,000 g for 30 min at 4°C. Then, the
supernatant was collected as the cytosolic fraction. This
isolated cytosolic fraction was subjected to western blot
analysis for cytochrome c release assay. Cytochrome c ex-
pression was analyzed with anti-cytochrome c polyclonal
antibody. An alkaline phosphatase-conjugated goat anti-
rabbit secondary antibody was used for this experiment.
For western blot analysis the protein concentration of the
clear supernatant was evaluated using Bio-Rad Protein
Assay Kit. Aliquots of equal amounts of proteins were
subjected to SDS–PAGE. Proteins were then electrophor-
etically transferred to nitrocellulose membrane and non-
specific sites were blocked with 5% skimmed milk in 1%
Tween-20 (Sigma-Aldrich) in 20 mM TBS (pH 7.5) and
reacted with the primary polyclonal antibody against cyto-
chrome c and b-actin for 4 h at room temperature.
After washing the tris-buffered saline containing 0.1%
Tween-20, the membrane was then incubated with al-
kaline phosphatase-conjugated goat anti-rabbit secondary
antibody. The protein bands were visualized using
NBT–BCIP.Statistical analysis
GraphPadInstat software was used for statistical ana-
lysis. All data are expressed as the mean ± S.D. of three
independent observations. The differences between the
control and the treatment groups were determined by
one-way analysis of variance (ANOVA). Post test was
done using Dunnette Multiple Comparison Test to de-
termine the significant levels.
Results
Antimutagenicity study by Ames test
Table 1 shows the results of antimutagenicity assays of
the DTE (concentrations 1, 10, 100, 500, 1000 μg/plate)
in Salmonella strains TA98 and TA100 by preincubation
tests with metabolic activation. The antimutagenicity as-
says in preincubation tests showed significant antimuta-
genic effects of DTE, specially at higher concentrations,
against the known positive mutagen B[a]P with S9 acti-
vation. In these assays the protective effects of DTE was
found to be upto 58.6% and 44% on TA98 and TA100
respectively at the highest dose against B[a]P.
Anticlastogenecity study by MN assay
Table 2 shows the results of anticlastogenic effects of
four different concentrations (25, 50, 100, 200 μg/ml) of
DTE against B[a]P as measured by micronuclei (MN)
formation in human lymphocyte cultures. A statistically
Table 2 Anticlastogenic effect of Darjeeling tea extract
(DTE) against benzo[a]pyrene (B[a]P) in human
lymphocyte culture as measured by micronuclei
formation
Clastogen (μM) DTE (μg/ml) Number of micronucleated
cells/1000 binucleated
cells (mean + _S.D.)
- 25 1.33 ± 1.22
- 50 1.27 ± 0.98
- 100 1.35 ± 1.08
- 200 2.63 ± 1.46
B[a]P 100 - 18.69 ± 3.39
B[a]P 100 25 15.62 ± 2.37 *
B[a]P 100 50 12.56 ± 2.77 **
B[a]P 100 100 8.07 ± 1.68 **
B[a]P 100 200 10.49 ± 3.12 **
Each data represented as Mean ± SD of six samples per concentration. Results
at of each concentration of DTE plus positive mutagen benzo[a]pyrene (B[a]P)
were compared with the positive mutagen treated group alone (all in presence
of S9 mix) by Dunnett’s multiple comparison. *P < 0.05, **P < 0.01.
Figure 1 Effects of Darjeeling tea extract (DTE) on the viability of U93
(PBMCs) (D) in the cell viability assay using WST-1 at different time p
concentrations (0, 25, 50, 100, 200 μg/ml) of DTE for 24 h (A), 48 h (B) and
only 48 h treatment data is represented here (D). The cell viability percenta
results are represented as mean ± SD (n = 3) taking control (only vehicle i.e
are the treated groups compared with control.
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tures of B[a]P post-treated with DTE at different concen-
trations when compared with the cultures that received B
[a]P only. In MN assay the protective effect of DTE was
found within a range of 16.4–56.8% in human lymphocyte
(in vitro). The effect was maximum at 100 μg/ml concen-
tration against the known positive mutagen B[a]P.
Cell viability assay using WST-1
The effects of DTE on the viability of U937 cells were
determined by obtaining the percentage of viable cells at
varying concentrations (0, 25, 50, 100, 200 μg/ml) of
DTE at different time points such as 24 h (Figure 1A),
48 h (Figure 1B) and 72 h (Figure 1C) of treatment re-
spectively. The results obtained in this assay clearly
shows that in each time points DTE have significant
growth inhibitory effect on the selected cell line. The
study also showed inhibition of U937 cell viability
upon treatment with DTE which is both dose and time
dependent. A similar experiment was performed on7 cells (A, B,C) and on peripheral blood mononuclear cells
oints. U937 cells (1 × 106 per treatment) were treated with different
72 h (C) in triplicate. Similar experiment was performed on PBMCs but
ge at each concentration of treatment is plotted. The experimental
. 0.05% DMSO treated group) as 100% viable. *p < 0.05 and **p < 0.01
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ment). At above 100 μg/ml dose DTE showed toxicity
towards PBMCs after 48 h of treatment (Figure 1D).
Further experiments were conducted taking 100 μg/ml
as highest concentration of DTE and the treatment
time was optimized as 48 h.
Induction of apoptosis in U937 cells upon treatment with
DTE
Induction of apoptosis by DTE on U937 cells was stud-
ied by means of Annexin V/propidium iodide double
staining method. The cells were treated with different
concentrations of DTE (0, 25, 50, 100 μg/ml) for 48 h.
and analysed by flow cytometry. The result indicates that
the different doses of DTE (25, 50, 100 μg/ml) can in-
duce apoptosis in U937 cells significantly and it ranged
from 7.4% to 35.9% from lower to higher concentrations
(Figure 2).
The induction of apoptosis by DTE was also evident
from the confocal microscopic study. The DTE treatedFigure 2 Flow cytometric detection of apoptosis induction by three d
treatment) were incubated with DTE at 0 μg/ml (A), 25 μg/ml (B), 50 μg/m
U937 cells was determined by the flow cytometry using double staining m
cells (B, C, D) were labeled with PI and AnnexinV tagged-Alexa Fluor and t
Alexa fluor-fluorescence (X-axis) versus PI fluorescence (Y-axis) has been sh
cells (− Alexa Fluor), lower right, apoptotic cells (+Alexa Fluor), upper right,
Numbers represented in each block here is the% of cells of lower right qcells showed typical apoptotic feature i.e. externalization
of phosphatidylserine on the outer surface of the treated
cells. Only a representative picture has been incorpo-
rated here (Figure 3).
Effect of DTE on caspase-3 activity
Activation of caspases is a hallmark sign of apoptotic cell
death. Among the caspase group caspase-3 is one of the
most common and important caspase protease that pro-
motes the execution phase of apoptosis. We examined
whether this specific caspase was involved in DTE induced
death of U937 cells. The activity of caspase-3 was exam-
ined after 48 h of treatment at different concentrations (0,
25, 50, 100 μg/ml). All fractions induced statistically signifi-
cant (p < 0.05 to p < 0.01) increase of the activity of
caspase-3 in U937 cells upon DTE treatment (Figure 4A).
Cytochrome c release in the cytosol
To confirm the result further, we investigated the release
of cytochrome c in cytosolic fraction of U937 cells toifferent doses of DTE at 48 h of treatment. U937 cells (1 × 106 per
l (C) and 100 μg/ml (D) doses for 48 h. DTE induced apoptosis in
ethod. Vehicle (0.05% DMSO only) treated control (A) and DTE treated
hen fixed and analyzed by flow cytometer. Dual parameter dot plot of
own in logarithmic fluorescence intensity. Quadrants: lower left, live
necrotic cells or late phase of apoptotic cells (+PI, + Alexa Fluor).
uadrant only.
Figure 3 Representative confocal pictures of DTE induced apoptotic cells. U937 cells were incubated with DTE at 50 μg/ml dose for 48 h
and after completion of stipulated time of treatment cells were labeled with FITC-AnnexinV (green fluorescence) and DAPI (blue fluorescence).
The first row is showing cells treated with vehicle only (0.05% DMSO). The second row is showing treated cells with DTE. The first (extreme left)
column showing merged (DAPI and FITC-AnnexinV) pictures, the second (middle) column showing only DAPI (blue) labeled cells, and the third
column showing only FITC-tagged AnnexinV (green) labeled cells. Data shown here are from a representative experiment repeated thrice with
similar results.
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cytochrome c appeared in the cytosolic fractions after
48 h of incubation with DTE in a dose dependent man-
ner (Figure 4B).
Discussions
Ongoing research for the last few decades have shown
that tea and its polyphenolic constituents can bring
about many protective biological activities including anti-
mutagenic and anticancer activities and consequently, tea
appears to be a good natural agent for chemoprevention.
Sufficient data have been generated asserting that prevent-
ive effects of green tea consumption on occurrence of
various types of cancer. Black tea and its polyphenols have
potentials to protect human beings from different detri-
mental health effect. Earlier reports are available on the
antimutagenic potential of black tea or its extracts on bac-
terial system [5].The main objective of this study was to investigate the
antimutagenic and/or anticancer activities of Darjeeling
tea extract (DTE). In this study, at first the mutagenic ef-
fects of DTE on bacterial system was monitored and no
significant mutagenic effect was observed in the concen-
trations tested for antimutagenicity assay (data not shown).
All the solvent control data and the mutagenicity assay
data were with the normal range as mentioned by Maron
and Ames [22]. Our experimental data indicates that DTE
exhibits protective effects in vitro on bacterial system espe-
cially at the higher concentrations against the known
mutagen B[a]P in presence of S9 mix. Result of this experi-
ment was in agreement with a previous study where black
tea polyphenols theaflavins and thearubigins showed sig-
nificant antimutagenic activity against the same mutagen
on bacterial systems [26].
To validate the data further the antimutagenic poten-
tial of DTE was tested in mammalian cell culture system
Figure 4 Activation of caspase-3 and release of cytochrome c upon DTE treatment. A: Caspase-3 activation after treatment with three
different concentrations of DTE in U937 cells. Cells were treated with 0, 25, 50 and 100 μg/ml of DTE for 48 h and then subjected to measure
caspase-3 activity by means of cleavage of the substrate DEVD-AFC. Each value was calculated as mean ± S.D. (n = 3). Bar diagram represents fold
change in caspase-3 activity taking vehicle control as 1 fold. B: Release of cytochrome c in cytosolic fraction of U937 cells after treatment with DTE in
dose-dependent manner. Cells were treated with DTE (0, 25, 50, 100 ug/ml) for 48 h. and were harvested and cytochrome c level in the cytosolic
fraction was determined by western blot. Protein from cytosolic fraction was subjected to SDS–PAGE and western blot using cytochrome c
and beta-actin antibody. Representative blot from three independent experiments was with identical results. Relative intensity of each band
after normalization with the intensity of beta-actin in a blot (below) was measured.
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assay result corroborates with the previous finding by
showing less number of micronuclei formed in presence
of DTE at different concentrations when compared with
the mutagen B[a]P treated group only.
Development of cancer is often related with multiple
mutations and hence it can be hypothesised that DTE
could have anticancer activity as it was found to be a po-
tent antimutagenic substance. Earlier it has been reported
that tea polyphenols having antimutagenic potential also
have anticancer effects [27]. Therefore, we subsequently
tried to evaluate the anticancer effect of DTE on cancer-
ous U937 cells. The objective of cell viability assay was to
assess the direct growth inhibitory effect of the DTE on
the proliferation and survival of the U937 cells [28]. Our
results depicted inhibitory effects of DTE on the U937
cells at different time point. Decrease in the percentage of
viable cells over a range of concentrations (0, 25, 50, 100,
200 μg/ml) of DTE at 24, 48 and 72 hours of treatment
was observed. The decrease in the percentage of vi-
able cells upon DTE treatment was found to be dose
dependent.
“Apoptosis” is a type of programmed cell death which
plays a very significant role in eliminating the hyperpro-
liferating cells from our body. Induction of apoptosis incancer cells, thus, can be considered as a protective
mechanism against development and progression of this
disease. In this study, we hypothesised that the loss of
cell viability of U937 cells upon treatment with DTE
could be due to the induction of apoptosis by the ex-
tract. Hence, we extended our study to find out the
apoptosis induction by the extract. It has been observed
that treatment with DTE resulted apoptosis in U937
cells as evident from Annexin V/propidium iodide double
staining method. This result suggests that the inhibition of
cell viability could be due to induction of apoptotic death
of U937 cells upon DTE treatment. The confocal micros-
copy result also showed externalization of phosphotydle
serine on the surface of DTE treated U937 cells which
support the earlier evident of apoptosis induction.
Activity of caspase-3 is in many cases related with the
apoptosis induction in cancer cells and an increase in
the activity of this proteolytic enzyme is considered as a
signature of the executionery phase of this process [29].
Here we found that, DTE, at all selected concentrations,
was able to upregulate the activity of caspase-3 upon
treatment in U937 cells. Another classical feature of
apoptotic death is release of mitochondrial cytochrome c
in cytosol [30]. We also investigated this phenomenon
on U937 cells after DTE treatment. It was found that in
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chrome c in cytosol of U937 cells at 48 hours of treat-
ment further proving the fact that DTE was able to
induce apoptosis in the selected cancer cell line.
Conclusion
Hence, this study demonstrated the antimutagenic and
anticancer activities of the Darjeeling tea extract. DTE
showed antimutagenic property on Salmonella strains in
bacterial mutagenicity assay and on human lymphocytes
in vitro with metabolic activation. DTE also showed in-
hibitory effect on the viability of the U937 cells. We fur-
ther found that DTE exerts its antiproliferative effect by
inducing apoptotic death in U937 cells. Therefore, it
could be concluded that DTE have anticancer effects
and could have chemopreventive properties.
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